Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

USP34 (ubiquitin specific peptidase 34)

Identity

Alias_namesubiquitin specific protease 34
Alias_symbol (synonym)KIAA0570
KIAA0729
Other alias-
HGNC (Hugo) USP34
LocusID (NCBI) 9736
Atlas_Id 57882
Location 2p15  [Link to chromosome band 2p15]
Location_base_pair Starts at 61187455 and ends at 61470714 bp from pter ( according to hg38-Dec_2013)
Fusion genes
(updated 2017)
Data from Atlas, Mitelman, Cosmic Fusion, Fusion Cancer, TCGA fusion databases with official HUGO symbols (see references in chromosomal bands)
BAG1 (9p13.3) / USP34 (2p15)C3 (19p13.3) / USP34 (2p15)GALNT13 (2q23.3) / USP34 (2p15)
HBA2 (16p13.3) / USP34 (2p15)HINT1 (5q23.3) / USP34 (2p15)UBAP2 (9p13.3) / USP34 (2p15)
USP34 (2p15) / BCAT2 (19q13.33)USP34 (2p15) / CARKD (13q34)USP34 (2p15) / CCT4 (2p15)
USP34 (2p15) / FAM161A (2p15)USP34 (2p15) / HERPUD1 (16q13)USP34 (2p15) / HSDL2 (9q32)
USP34 (2p15) / RFC4 (3q27.3)USP34 (2p15) / TUBGCP3 (13q34)USP34 (2p15) / USP34 (2p15)
USP34 (2p15) / WDR92 (2p14)USP34 (2p15) / ZNF638 (2p13.2)

Note

Non-annotated gene. Preliminary data : if you are an author
who wish to write a full paper/card on this gene, go to  How to contribute

DNA/RNA

 


Other Solid tumors implicated (Data extracted from papers in the Atlas) [ 2 ]

Solid Tumors TT_t0202p13p15ID105141 TT_t0209p15p13ID105540


External links

Nomenclature
HGNC (Hugo)USP34   20066
Cards
Entrez_Gene (NCBI)USP34  9736  ubiquitin specific peptidase 34
Aliases
GeneCards (Weizmann)USP34
Ensembl hg19 (Hinxton) [Gene_View]
Ensembl hg38 (Hinxton) [Gene_View]   [Sequence]  chr2:61187455-61470714 [Contig_View]  USP34 [Vega]
TCGA cBioPortalUSP34
AceView (NCBI)USP34
Genatlas (Paris)USP34
WikiGenes9736
SOURCE (Princeton)USP34
Genetics Home Reference (NIH)USP34
Genomic and cartography
GoldenPath hg38 (UCSC)USP34  -     chr2:61187455-61470714 -  2p15   [Description]    (hg38-Dec_2013)
GoldenPath hg19 (UCSC)USP34  -     2p15   [Description]    (hg19-Feb_2009)
GoldenPathUSP34 - 2p15 [CytoView hg19]  USP34 - 2p15 [CytoView hg38]
Mapping of homologs : NCBIUSP34 [Mapview hg19]  USP34 [Mapview hg38]
OMIM615295   
Gene and transcription
Genbank (Entrez)AB011142 AB018272 AJ586138 AK001193 AK022637
RefSeq transcript (Entrez)NM_014709
RefSeq genomic (Entrez)
Consensus coding sequences : CCDS (NCBI)USP34
Gene ExpressionUSP34 [ NCBI-GEO ]   USP34 [ EBI - ARRAY_EXPRESS ]   USP34 [ SEEK ]   USP34 [ MEM ]
Gene Expression Viewer (FireBrowse)USP34 [ Firebrowse - Broad ]
SOURCE (Princeton)Expression in : [Datasets]   [Normal Tissue Atlas]  [carcinoma Classsification]  [NCI60]
BioGPS (Tissue expression)9736
GTEX Portal (Tissue expression)USP34
Protein : pattern, domain, 3D structure
Domain families : Pfam (Sanger)
Domain families : Pfam (NCBI)
Conserved Domain (NCBI)USP34
DMDM Disease mutations9736
Blocks (Seattle)USP34
IPIIPI00297593   IPI00787401   IPI00894492   IPI00914601   IPI00982046   IPI00941592   IPI00927157   
Protein Interaction databases
BioGRIDUSP34
STRING (EMBL)USP34
ZODIACUSP34
Ontologies - Pathways
Huge Navigator USP34 [HugePedia]
snp3D : Map Gene to Disease9736
BioCentury BCIQUSP34
ClinGenUSP34
Clinical trials, drugs, therapy
Chemical/Protein Interactions : CTD9736
Chemical/Pharm GKB GenePA134897042
Clinical trialUSP34
Miscellaneous
canSAR (ICR)USP34 (select the gene name)
DataMed IndexUSP34
Probes
Litterature
PubMed38 Pubmed reference(s) in Entrez
GeneRIFsGene References Into Functions (Entrez)
CoreMineUSP34
EVEXUSP34
GoPubMedUSP34
iHOPUSP34
Genes in titleautomatic search in PubMed
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Feb 19 17:15:55 CET 2020

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.